The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

Emirates Global Aluminium restarts production at Al Taweelah alumina refinery
Dubai Customs gears up for summer travel surge
New control centre to monitor autonomous vehicles in Abu Dhabi
UAE supports Syrian efforts to dismantle terrorist cells
